These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

676 related items for PubMed ID: 18052934

  • 1. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT, Charles CJ, Nicholls MG, Richards AM.
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [Abstract] [Full Text] [Related]

  • 2. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT, Charles CJ, Nicholls MG, Richards AM.
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [Abstract] [Full Text] [Related]

  • 3. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT, Charles CJ, Cooper GJ, Coy DH, Espiner EA, Lewis LK, Nicholls MG, Richards AM.
    Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
    [Abstract] [Full Text] [Related]

  • 4. Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure.
    Rademaker MT, Cameron VA, Charles CJ, Richards AM.
    Circulation; 2005 Dec 06; 112(23):3624-32. PubMed ID: 16330704
    [Abstract] [Full Text] [Related]

  • 5. Urocortin 2 sustains haemodynamic and renal function during introduction of beta-blockade in experimental heart failure.
    Rademaker MT, Charles CJ, Nicholls G, Richards M.
    J Hypertens; 2011 Sep 06; 29(9):1787-95. PubMed ID: 21720262
    [Abstract] [Full Text] [Related]

  • 6. Interactions of enhanced urocortin 2 and mineralocorticoid receptor antagonism in experimental heart failure.
    Rademaker MT, Charles CJ, Nicholls MG, Richards AM.
    Circ Heart Fail; 2013 Jul 06; 6(4):825-32. PubMed ID: 23753530
    [Abstract] [Full Text] [Related]

  • 7. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
    Seymour AA, Asaad MM, Lanoce VM, Langenbacher KM, Fennell SA, Rogers WL.
    J Pharmacol Exp Ther; 1993 Aug 06; 266(2):872-83. PubMed ID: 8394922
    [Abstract] [Full Text] [Related]

  • 8. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J, Marie C, Mossiat C, Lecomte JM, Gros C, Schwartz JC.
    J Pharmacol Exp Ther; 1994 Jul 06; 270(1):8-14. PubMed ID: 8035346
    [Abstract] [Full Text] [Related]

  • 9. Acute hemodynamic effects of drugs acting on the renin-angiotensin system in acute heart failure.
    Nekooeian AA, Ogilvie RI, Zborowska-Sluis D.
    Can J Cardiol; 1995 Jan 06; 11(1):59-64. PubMed ID: 7850666
    [Abstract] [Full Text] [Related]

  • 10. Prolonged urocortin 2 administration in experimental heart failure: sustained hemodynamic, endocrine, and renal effects.
    Rademaker MT, Charles CJ, Ellmers LJ, Lewis LK, Nicholls MG, Richards AM.
    Hypertension; 2011 Jun 06; 57(6):1136-44. PubMed ID: 21536988
    [Abstract] [Full Text] [Related]

  • 11. Hemodynamic, hormonal, and renal actions of adrenomedullin 2 in experimental heart failure.
    Rademaker MT, Charles CJ, Nicholls MG, Richards AM.
    Circ Heart Fail; 2008 Jul 06; 1(2):134-42. PubMed ID: 19808282
    [Abstract] [Full Text] [Related]

  • 12. [ACE inhibition: mechanisms of cardioprotection in chronic experimental heart failure].
    Riegger AJ.
    Klin Wochenschr; 1991 Jul 06; 69 Suppl 24():20-3. PubMed ID: 1830909
    [Abstract] [Full Text] [Related]

  • 13. Four-day urocortin-I administration has sustained beneficial haemodynamic, hormonal, and renal effects in experimental heart failure.
    Rademaker MT, Charles CJ, Espiner EA, Frampton CM, Lainchbury JG, Richards AM.
    Eur Heart J; 2005 Oct 06; 26(19):2055-62. PubMed ID: 15961410
    [Abstract] [Full Text] [Related]

  • 14. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading.
    Tomiyama H, Watanabe G, Abe M, Okazaki R, Yoshida H, Doba N.
    Am Heart J; 2001 Mar 06; 141(3):422-7. PubMed ID: 11231440
    [Abstract] [Full Text] [Related]

  • 15. Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy.
    de Resende MM, Kriegel AJ, Greene AS.
    J Cardiovasc Pharmacol; 2006 Dec 06; 48(6):265-73. PubMed ID: 17204904
    [Abstract] [Full Text] [Related]

  • 16. Urocortin 3: haemodynamic, hormonal, and renal effects in experimental heart failure.
    Rademaker MT, Cameron VA, Charles CJ, Richards AM.
    Eur Heart J; 2006 Sep 06; 27(17):2088-98. PubMed ID: 16825287
    [Abstract] [Full Text] [Related]

  • 17. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J, Smit AJ, de Graeff PA, van Gilst WH, van der Broek SA, van Veldhuisen DJ, Lie KI, Wesseling H.
    J Cardiovasc Pharmacol; 1994 Feb 06; 23(2):240-5. PubMed ID: 7511753
    [Abstract] [Full Text] [Related]

  • 18. Captopril does not prevent nitroglycerin tolerance in heart failure.
    Dupuis J, Lalonde G, Bichet D, Rouleau JL.
    Can J Cardiol; 1990 Sep 06; 6(7):281-6. PubMed ID: 2121325
    [Abstract] [Full Text] [Related]

  • 19. [Does captopril decrease endothelial production of endothelin?].
    Mazurek W, Halawa B.
    Pol Merkur Lekarski; 1997 Sep 06; 3(15):105-8. PubMed ID: 9461703
    [Abstract] [Full Text] [Related]

  • 20. Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep.
    Rademaker MT, Charles CJ, Espiner EA, Fisher S, Frampton CM, Kirkpatrick CM, Lainchbury JG, Nicholls MG, Richards AM, Vale WW.
    J Am Coll Cardiol; 2002 Oct 16; 40(8):1495-505. PubMed ID: 12392842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.